Abstract | PURPOSE: This study aims to demonstrate that pulsed high-intensity focused ultrasound (pulsed-HIFU) may enhance the fructose-conjugated 4-borono-L-phenylalanine (BPA-Fr) accumulation in tumor lesion using (18)F-FBPA-Fr microPET scans. PROCEDURES: To the mice bearing orthotopic SASC03 human tongue squamous carcinoma xenograft, a 2-min pulsed-HIFU was applied to tumor. Immediately after pulsed-HIFU treatment, (18)F-FBPA-Fr was intravenously injected, and biological characterizations including microPET imaging and biodistribution were conducted. RESULTS: Both biodistribution studies and microPET imaging performed after intravenous injection of (18)F-FBPA-Fr revealed higher tumor uptake in HIFU-treated mice than that of the control. CD31 and Ki-67 histochemical staining of tumor sections and H&E staining of nearby normal tissues revealed no significant difference between the pulsed-HIFU-treated mice and the control. CONCLUSION: This study demonstrated that pulsed-HIFU was beneficial to the accumulation of boron drug in the head and neck tumor lesion and may enhance the therapeutic efficacy of clinical BNCT.
|
Authors | Chun-Yi Wu, Pei-Chia Chan, Lin-Shan Chou, Chi-Wei Chang, Feng-Yi Yang, Ren-Shyan Liu, Shih-Hwa Chiou, Yi-Wei Chen, Sang-Hue Yen, Hsin-Ell Wang |
Journal | Molecular imaging and biology
(Mol Imaging Biol)
Vol. 16
Issue 1
Pg. 95-101
(Feb 2014)
ISSN: 1860-2002 [Electronic] United States |
PMID | 23925592
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 4-borono-2-fluorophenylalaninefructose
- Boron Compounds
- Glycopeptides
|
Topics |
- Animals
- Area Under Curve
- Boron Compounds
(pharmacology)
- Carcinoma, Squamous Cell
(diagnostic imaging, pathology)
- Cell Line, Tumor
- Glycopeptides
(pharmacology)
- Head and Neck Neoplasms
(diagnostic imaging, pathology)
- High-Intensity Focused Ultrasound Ablation
- Humans
- Mice
- Positron-Emission Tomography
- Tissue Distribution
(drug effects)
- Tomography, X-Ray Computed
- Tongue Neoplasms
(diagnostic imaging, pathology)
- Xenograft Model Antitumor Assays
|